Entrada Therapeutics
TRDA
TRDA
56 hedge funds and large institutions have $390M invested in Entrada Therapeutics in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 12 closing their positions.
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
0.88%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
18
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$21.3M |
2 |
2
State Street
Boston,
Massachusetts
|
$5.92M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$6.07M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$2.94M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$15.3M |